Works matching IS 10781552 AND DT 2019 AND VI 25 AND IP 6
Results: 38
Evaluation of potentially inappropriate medication utilization in elderly patients with cancer at outpatient oncology unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1321, doi. 10.1177/1078155218788698
- By:
- Publication type:
- Article
Gastrointestinal stromal tumor – A review of clinical studies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1473, doi. 10.1177/1078155219846955
- By:
- Publication type:
- Article
Potential role of rituximab in metastatic castrate-resistant prostate cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1509, doi. 10.1177/1078155218790338
- By:
- Publication type:
- Article
Hepatitis B virus reactivation following imatinib therapy: A comparative review of 9 cases.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1500, doi. 10.1177/1078155218790337
- By:
- Publication type:
- Article
Optimizing patient education of oncology medications: A quantitative analysis of the patient perspective.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1445, doi. 10.1177/1078155219843675
- By:
- Publication type:
- Article
Work overload is related to increased risk of error during chemotherapy preparation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1456, doi. 10.1177/1078155219845432
- By:
- Publication type:
- Article
What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1439, doi. 10.1177/1078155219843161
- By:
- Publication type:
- Article
Vision loss with pembrolizumab treatment: A report of two cases.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1540, doi. 10.1177/1078155219841683
- By:
- Publication type:
- Article
Stability studies of two compounded solutions potentially used in tumor lysis syndrome.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1434, doi. 10.1177/1078155219840421
- By:
- Publication type:
- Article
Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1425, doi. 10.1177/1078155219839458
- By:
- Publication type:
- Article
Moxetumomab pasudotox: A first-in-class treatment for hairy cell leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1467, doi. 10.1177/1078155219838041
- By:
- Publication type:
- Article
Implementation of a student pharmacist-driven medication history service for ambulatory oncology patients in a large academic medical center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1419, doi. 10.1177/1078155219831066
- By:
- Publication type:
- Article
Off-label versus on-label prescribing of oral oncology agents on time to receipt of medication in patients with soft tissue sarcoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1412, doi. 10.1177/1078155219830471
- By:
- Publication type:
- Article
Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: Patient case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1534, doi. 10.1177/1078155219830162
- By:
- Publication type:
- Article
Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1402, doi. 10.1177/1078155219829813
- By:
- Publication type:
- Article
Cetirizine versus diphenhydramine in the prevention of chemotherapy-related hypersensitivity reactions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1396, doi. 10.1177/1078155218811505
- By:
- Publication type:
- Article
Successful re-introduction of alectinib after inducing interstitial lung disease in a patient with lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1531, doi. 10.1177/1078155218820580
- By:
- Publication type:
- Article
The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1312, doi. 10.1177/1078155218786048
- By:
- Publication type:
- Article
Retrospective evaluation of a rechallenge protocol in patients experiencing hypersensitivity reactions with prior chemotherapy in a tertiary hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1388, doi. 10.1177/1078155218796190
- By:
- Publication type:
- Article
Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1381, doi. 10.1177/1078155218795323
- By:
- Publication type:
- Article
Time to treatment failure of palbociclib and letrozole as second-line therapy or beyond in hormone receptor-positive advanced breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1374, doi. 10.1177/1078155218794847
- By:
- Publication type:
- Article
Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1366, doi. 10.1177/1078155218792985
- By:
- Publication type:
- Article
Overuse and underuse of pegfilgrastim for primary prophylaxis of febrile neutropenia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1357, doi. 10.1177/1078155218792698
- By:
- Publication type:
- Article
Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1526, doi. 10.1177/1078155218792672
- By:
- Publication type:
- Article
Subcutaneous auto-administration of trastuzumab following therapeutic education: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1523, doi. 10.1177/1078155218792364
- By:
- Publication type:
- Article
Single 6-mg dose of rasburicase: The experience in a large academic medical center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1349, doi. 10.1177/1078155218791333
- By:
- Publication type:
- Article
Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1520, doi. 10.1177/1078155218791314
- By:
- Publication type:
- Article
Transformation of a non-secretory neuroendocrine tumor to insulinoma after treatment with Sunitinib: A case report and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1516, doi. 10.1177/1078155218791309
- By:
- Publication type:
- Article
Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1343, doi. 10.1177/1078155218790798
- By:
- Publication type:
- Article
A unique schedule of palonosetron, ondansetron, and dexamethasone for the prevention of delayed nausea and vomiting in patients receiving myeloablative chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1336, doi. 10.1177/1078155218790345
- By:
- Publication type:
- Article
Long-lasting response with polycythemia to third-line axitinib treatment in metastatic renal cell carcinoma: Very rare case presentation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1512, doi. 10.1177/1078155218790342
- By:
- Publication type:
- Article
Toxicity and effectiveness of carboplatin in obese or overweight patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1328, doi. 10.1177/1078155218790339
- By:
- Publication type:
- Article
Acute encephalopathy secondary to dabrafenib and trametinib in BRAF-positive metastatic adenocarcinoma of the lung.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1497, doi. 10.1177/1078155218790331
- By:
- Publication type:
- Article
Initiation of venovenous extracorporeal membrane oxygenation in a patient receiving induction chemotherapy for acute myelogenous leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1491, doi. 10.1177/1078155218788735
- By:
- Publication type:
- Article
Cerebral aspergillosis in a patient on ibrutinib therapy—A predisposition not to overlook.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1486, doi. 10.1177/1078155218788717
- By:
- Publication type:
- Article
Evaluating a voriconazole dose modification guideline to optimize dosing in patients with hematologic malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1305, doi. 10.1177/1078155218786028
- By:
- Publication type:
- Article
Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1301, doi. 10.1177/1078155218784760
- By:
- Publication type:
- Article
Real world evidence: Abiraterone use post-docetaxel in metastatic castrate-resistant prostate cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1293, doi. 10.1177/1078155218784716
- By:
- Publication type:
- Article